Clinical Trial

Sustained Release Lidocaine for the Treatment of Postoperative Pain

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2025 (before its estimated April 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, the investigators are testing a new formulation of lidocaine for its suitability in managing postoperative pain after pelvic (circumcision, inguinal, scrotal), perineal (hemorrhoidectomy) or perianal (fistulotomy) incisions. The new formulation ST-01 is a sustained release lidocaine formulation and is expected to provide pain relief over multiple days. Currently, the drug lidocaine is not available as an injectable slow-release formulation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-12-31; most recent amendment 2025-02-04.
Trial Details
NCT Number NCT05193227
Lead Sponsor University of British Columbia
Collaborators: Sustained Therapeutics Inc.
Conditions Postoperative Pain, Postsurgical Pain
Enrollment 120 participants
Start Date 2021-10-27
Primary Completion 2026-04-27 (estimated)
Study Completion 2026-05-27 (estimated)
Updated on ClinicalTrials.gov 2025-02-07